RNC Pharma reports that in October 2024, Russians' total expenditure on pharmaceuticals reached an unprecedented 151.6 billion rubles, marking a new historical high. From...
Clinical trials for anti-cancer drugs developed by R-Pharm Group are currently underway at the University Clinical Hospital No. 1, affiliated with Sechenov University. The...
The Russian Ministry of Health is drafting an amendment to Federal Law to enhance medicine provision for adult patients with orphan diseases. The document...
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
